REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2017

Dec 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2017-12-12

Reporting Person: LAROSA JOSEPH J (SVP General Counsel and Secret)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-12	Non-Qualified Stock Option (right to buy)	$378.98	A	23337	Acquired	2027-12-12	Common Stock (23337)	Direct

Footnotes

F1: The stock option award vests in four equal annual installments, commencing one year after the date of grant.